Two-stage hepatectomy with effective perioperative chemotherapy does not induce tumor growth or growth factor expression in liver metastases from colorectal cancer

Surgery (United States)

Volumn 153, Issue 2, 2013, Pages 179-188

  Tanaka, Kuniya ^a   Hiroshima, Yukihiko ^a   Nakagawa, Kazuya ^a   Kumamoto, Takafumi ^a   Nojiri, Kazunori ^a   Takeda, Kazuhisa ^a   Ota, Mitsuyoshi ^a   Ichikawa, Yasushi ^a   Endo, Itaru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLIN D1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR; KI 67 ANTIGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ABDOMINAL ABSCESS; ABSCESS; ARTICLE; ASCITES; BILE DUCT FISTULA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; DELIRIUM; DISEASE COURSE; FEMALE; HUMAN; KIDNEY FAILURE; LIVER METASTASIS; LIVER REGENERATION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYREXIA IDIOPATHICA; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; WOUND INFECTION;

ADULT; AGED; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLINS; DRUG THERAPY; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872486269     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.06.026     Document Type: Article

References (61)

1. R. Adam, A. Laurent, D. Azoulay, D. Castaing, and H. Bismuth Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors Ann Surg 232 2000 777 785
2. E.K. Abdalla, M.E. Hicks, and J.N. Vauthey Portal vein embolization: rationale, technique and future prospects Br J Surg 88 2001 165 175
3. O. Farges, J. Belghiti, R. Kianmanesh, J.M. Regimbeau, R. Santoro, and V. Vilgrain Portal vein embolization before right hepatectomy: prospective clinical trial Ann Surg 237 2003 208 217
4. D. Jaeck, P. Bachellier, H. Nakano, E. Oussoultzoglou, J.C. Weber, and P. Wolf One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases Am J Surg 185 2003 221 229
5. G.Y. Ko, K.B. Sung, H.K. Yoon, J.H. Kim, Y.C. Weon, and H.Y. Song Preoperative portal vein embolization with a new liquid embolic agent Radiology 227 2003 407 413
6. K. Tanaka, H. Shimada, K. Matsuo, M. Ueda, I. Endo, and S. Togo Two-stage hepatectomy in treatment of multiple bilobar colorectal metastases: remnant liver regeneration compared with portal vein embolization preceding one-stage hepatectomy Eur J Surg Oncol 33 2007 329 335
7. R. Kianmanesh, O. Farges, E.K. Abdalla, A. Sauvanet, P. Ruszniewski, and J. Belghiti Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases J Am Coll Surg 197 2003 164 170
8. D. Jaeck, E. Oussoultzoglou, E. Rosso, M. Greget, J.C. Weber, and P. Bachellier A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases Ann Surg 240 2004 1037 1051
9. D.A. Wicherts, R. Miller, R.J. de Haas, G. Bitsakou, E. Vibert, and L.A. Veilhan Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases Ann Surg 248 2008 994 1005
10. W. Jiang, S. Hiscox, K. Matsumoto, and T. Nakamura Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer Crit Rev Oncol Hematol 29 1999 209 248
11. B. Lukomska, J. Dluzniewska, J. Polanski, and L. Zajac Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration Comp Hepatol 3 Suppl 1 2004 S52
12. S.S. Yoon, S.H. Kim, M. Gonen, N.M. Heffernan, K.Y. Detwiller, and W.R. Jarnagin Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases Ann Surg Oncol 13 2006 353 362
13. N. Harun, M. Nikfarjam, V. Muralidharan, and C. Christophi Liver regeneration stimulates tumor metastases J Surg Res 138 2007 284 290
14. W.G. Jiang, M.B. Hallett, and M.C. Puntis Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis Br J Surg 80 1993 1368 1373
15. N. Kokudo, K. Tada, M. Seki, H. Ohta, K. Azekura, and M. Ueno Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization Hepatology 34 2001 267 272
16. G. Folprecht, A. Grothey, S. Alberts, H.R. Raab, and C.H. Köhne Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 2005 1311 1319
17. G. Mentha, S. Terraz, P. Morel, A. Andres, E. Giostra, and A. Roth Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases Br J Surg 96 2009 95 103
18. N. Yamanaka, E. Okamoto, T. Oriyama, J. Fujimoto, K. Furukawa, and E. Kawamura A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use Ann Surg 219 1994 342 346
19. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
20. P.A. Clavien, J. Barkun, M.L. de Oliveira, J.N. Vauthey, D. Dindo, and R.D. Schulick The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
21. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
22. K. Tanaka, T. Kumamoto, R. Matsuyama, K. Takeda, Y. Nagano, and I. Endo Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases J Gastrointest Surg 14 2010 359 368
23. C. Christophi, N. Harun, and T. Fifis Liver regeneration and tumor stimulation: a review of cytokine and angiogenic factors J Gastrointest Surg 12 2008 966 980
24. H. Yamagami, M. Moriyama, N. Tanaka, and Y. Arakawa Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases Intervirology 44 2001 36 42
25. J. Guirouilh, M. Castroviejo, C. Balabaud, A. Desmouliere, and J. Rosenbaum Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts Int J Oncol 17 2000 777 781
26. N. Rahimi, E. Tremblay, L. McAdam, M. Park, R. Schwall, and B. Elliott Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma Cell Growth Differ 7 1996 263 270
27. B.M. Arkonac, L.C. Foster, N.E. Sibinga, C. Patterson, K. Lai, and J.C. Tsai Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells J Biol Chem 273 1998 4400 4405
28. M.F. Di Renzo, M. Olivero, A. Giacomini, H. Porte, E. Chastre, and L. Mirossay Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer Clin Cancer Res 1 1995 147 154
29. G.K. Michalopoulos, and Z. Khan Liver regeneration, growth factors, and amphiregulin Gastroenterology 128 2005 503 506
30. J.P. Spano, C. Lagorce, D. Atlan, G. Milano, J. Domont, and R. Benamouzig Impact of EGFR expression on colorectal cancer patient prognosis and survival Ann Oncol 16 2005 102 108
31. D.I. Park, M.S. Kang, S.J. Oh, H.J. Kim, Y.K. Cho, and C.I. Sohn HER-2/neu overexpression is an independent prognostic factor in colorectal cancer Int J Colorectal Dis 22 2007 491 497
32. A.K. Greene, S. Wiener, M. Puder, A. Yoshida, B. Shi, and A.R. Perez-Atayde Endothelial-directed hepatic regeneration after partial hepatectomy Ann Surg 237 2003 530 535
33. K.P. de Jong, M.J. Slooff, E.G. de Vries, M.A. Brouwers, and O.T. Terpstra Effect of partial liver resection on tumour growth J Hepatol 25 1996 109 121
34. M. Narita, E. Oussoultzoglou, D. Jaeck, P. Fuchschuber, E. Rosso, and P. Pessaux Two-stage hepatectomy for multiple bilobar colorectal liver metastases Br J Surg 98 2011 1463 1475
35. Y.S. Chun, J.N. Vauthey, D. Ribero, M. Donadon, J.T. Mullen, and C. Eng Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival J Gastrointest Surg 11 2007 1498 1505
36. A. Brouquet, E.K. Abdalla, S. Kopetz, C.R. Garrett, M.J. Overman, and C. Eng High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome J Clin Oncol 29 2011 1083 1090
37. V. Pamecha, B. Nedjat-Shokouhi, K. Gurusamy, G.K. Glantzounis, D. Sharma, and B.R. Davidson Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases Dig Surg 25 2008 387 393
38. K. Homayounfar, T. Liersch, G. Schuetze, M. Niessner, A. Goralczyk, and J. Meller Two-stage hepatectomy (R0) with portal vein ligation: towards curing patients with extended bilobular colorectal liver metastases Int J Colorectal Dis 24 2009 409 418
39. M. Karoui, L. Vigano, P. Goyer, A. Ferrero, A. Luciani, and M. Aglietta Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases Br J Surg 97 2010 1354 1362
40. S. Tsai, H.P. Marques, M.C. de Jong, P. Mira, V. Ribeiro, and M.A. Choti Two-stage strategy for patients with extensive bilateral colorectal liver metastases HPB (Oxford) 12 2010 62 69
41. R. Chandra, C.H. Pilgrim, and V. Usatoff Staged liver resection for colorectal metastases: a valuable strategy or a waste of time? Hepatobiliary Pancreat Dis Int 9 2010 600 604
42. R. Kianmanesh, A. Sauvanet, O. Hentic, A. Couvelard, P. Lévy, and V. Vilgrain Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection Ann Surg 247 2008 659 665
43. A. Falcone, S. Ricci, I. Brunetti, E. Pfanner, G. Allegrini, and C. Barbara Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 2007 1670 1676
44. G. Folprecht, T. Gruenberger, W.O. Bechstein, H.R. Raab, F. Lordick, and J.T. Hartmann Tumour response and secondary resectability of colorectal liver metastases after neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 2010 38 47
45. N.E. Kemeny, F.D. Melendez, M. Capanu, P.B. Paty, Y. Fong, and L.H. Schwartz Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma J Clin Oncol 27 2009 3465 3471
46. R. Adam, G. Pascal, D. Castaing, D. Azoulay, V. Delvart, and B. Paule Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg 240 2004 1052 1064
47. K.C. Lee, H. Kinoshita, K. Hirohashi, S. Kubo, and R. Iwasa Extension of surgical indications for hepatocellular carcinoma by portal vein embolization World J Surg 17 1993 109 115
48. M. Nagino, Y. Nimura, J. Kamiya, S. Kondo, K. Uesaka, and Y. Kin Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization Hepatology 21 1995 434 439
49. N. Yamanaka, E. Okamoto, E. Kawamura, T. Kato, T. Oriyama, and J. Fijimoto Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function Hepatology 18 1993 79 85
50. T. Shimamura, Y. Nakajima, Y. Une, T. Namieno, K. Ogasawara, and K. Yamashita Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study Surgery 121 1997 135 141
51. T. de Baere, A. Roche, D. Vavasseur, E. Therasse, S. Indushekar, and D. Elias Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery Radiology 188 1993 73 77
52. M.L. Bucher, and M.N. Swaffield Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon Proc Natl Acad Sci U S A 72 1975 1157 1160
53. J.R. Duncan, M.E. Hicks, S.R. Cai, E.M. Brunt, and K.P. Ponder Embolization of portal vein branches induces hepatocyte replication in swine: a potential step in hepatic gene therapy Radiology 210 1999 467 477
54. N. Fausto Liver regeneration J Hepatol 32 2000 19 31
55. T. Gruenberger, B. Gruenberger, and W. Scheithauer Neoadjuvant therapy with bebacizunab J Clin Oncol 24 2006 2592 2593
56. S. Hayashi, Y. Baba, K. Ueno, M. Nakajo, F. Kubo, and S. Ueno Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization Acta Radiol 48 2007 721 727
57. B. Barbaro, C. Di Stasi, G. Nuzzo, M. Vellone, F. Giuliante, and P. Marano Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE Acta Radiol 44 2003 98 102
58. D. Elias, T. de Baere, A. Roche, M. Ducreux, J. Leclere, and P. Lasser During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma Br J Surg 86 1999 784 788
59. V. Pamecha, A. Levene, F. Grillo, N. Woodward, A. Dhillon, and B.R. Davidson Effect of portal vein embolisation on the growth rate of colorectal liver metastases Br J Cancer 100 2009 617 622
60. A. Picardo, H.M. Karpoff, B. Ng, J. Lee, M.F. Brennan, and Y. Fong Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation Surgery 124 1998 57 64
61. D.T. Schindel, and J.L. Grosfeld Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide J Pediatr Surg 32 1997 995 998